Use of inhaled nitric oxide in the preterm infant
- 1 April 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pediatrics
- Vol. 19 (2) , 137-141
Abstract
Inhaled nitric oxide is established therapy for term infants with hypoxemic respiratory failure. Laboratory studies demonstrate that inhaled nitric oxide improves lung function and morphology in animal models of bronchopulmonary dysplasia, creating a rationale for clinical studies in premature infants. Four large multicenter randomized trials have now completed enrollment, and one trial has reported neurodevelopmental outcomes at 18-22 months. The purpose of this review is to summarize the results of the most recent preclinical studies and clinical trials. In 2006, short-term outcomes from two large multicenter randomized trials were published. These studies differed in their target population and study design. Early use of inhaled nitric oxide was associated with a decrease in brain injury, and decreased chronic lung disease in infants over 1000 g. Inhaled nitric oxide use in older infants (7-21 days) was associated with decreased chronic lung disease, particularly if started early. Neurodevelopmental outcomes after discharge are still needed from three large multicenter randomized trials. These results will help confirm the long-term implications of the benefits reported in the two most recent trials.Keywords
This publication has 28 references indexed in Scilit:
- Neonatal Ventilation With Inhaled Nitric Oxide Versus Ventilatory Support Without Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure: The INNOVO Multicentre Randomised Controlled Trial (ISRCTN 17821339)Pediatrics, 2005
- A pilot study of inhaled nitric oxide in preterm infants treated with nasal continuous positive airway pressure for respiratory distress syndromeIntensive Care Medicine, 2005
- The safety and efficacy of nitric oxide therapy in premature infantsThe Journal of Pediatrics, 2005
- Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trialThe Lancet, 1999
- Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trialThe Lancet, 1999
- Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infantsArchives of Disease in Childhood - Fetal and Neonatal Edition, 1997
- Response of premature infants with severe respiratory failure to inhaled nitric oxidePediatric Pulmonology, 1997
- Nitric oxide inhalation in infants with respiratory distress syndromeThe Journal of Pediatrics, 1997
- Response to inhalative nitric oxide in a severely acidotic preterm newborn with lung hypoplasiaEuropean Journal of Pediatrics, 1996
- Inhaled nitric oxide for premature infants after prolonged rupture of the membranesThe Journal of Pediatrics, 1995